BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 12, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for July 12, 2021

July 12, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Bardy Diagnostics, Dariohealth, Hillrom, Histosonics, Tada Medical.
Read More
Coronavirus microscopic model

Inotrem lands $53M funding for pivotal COVID-19 trial of nangibotide

July 12, 2021
By Cormac Sheridan
DUBLIN – Inotrem SA has received €45 million (US$53 million) in public funding commitments to move its Trem-1 inhibitor, nangibotide, into a phase II/III trial in COVID-19 patients who are critically ill and on ventilation.
Read More

Regulatory actions for July 12, 2021

July 12, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Bluebird, Humanigen, Innovent, Lysogene.
Read More

Other news to note for July 12, 2021

July 12, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 48Hour, ABL, Aim Immunotech, Algernon, Arctic, Biocopy, Biological E, Biomarck, Bionomics, Biophytis, Camp4, Clionix, Daré, Dynavax, Eureka, Fastback, GT, Hummingbird, Ico, Immatics, Inceptor, Infectopharm, Innovent, Inveniai, Kedrion, Kymera, Laekna, Liminal, M8, Marinomed, MD Anderson, Medexus, Medac, Memorial Sloan Kettering, Moderna, Nicox, Novamind, Nrx, Nymirum, Ocumension, Open Orphan, Opko, Pierre Fabre, Polpharma, Poxel, Q Biomed, Rayzebio, SAB, Sanofi, Seelos, Servier, Sinovac, Sosei, Stallergenes, Surrozen, Teva, Thetis, Trevena, University Of Minnesota, Y-biologics.
Read More

In the clinic for July 12, 2021

July 12, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim Immunotech, Applied Molecular Transport, Arcutis, Ascendis, Bausch + Lomb, Bacainn, Biocryst, Evgen, Galapagos, Hansa, Janssen, Mediwound, Molecular Templates, Morphic, Ocugen, Oryzon, Pharnext, Rakuten, Reithera, Rhovac, Seelos, Summit, Takeda.
Read More

Other news to note for July 9, 2021

July 9, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Eurofins, Lazurite, J&J, Mission Bio, Quantumdx, Rite Aid, Sequanta Technologies.
Read More

Other news to note for July 9, 2021

July 9, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Alerje, Beacon, Bioasis, Biogen, Biontech, Bridgebio, Codexis, Corat, Cybin, Cyclerion, Dermapharm, Ensysce, Exscientia, ICER, I-Mab, Immorna, Ischemix, J&J, Janssen, Medolife, Neox Biotech, NMD, Pfizer, Puretech, Sunshine, Quanta, Virpax, Vor.
Read More

In the clinic for July 9, 2021

July 9, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aicuris, Akston, Astrazeneca, Atyr, Can-Fite, Daiichi Sankyo, Evaxion, Jiangsu Nhwa, Oncopeptides, Prilenia, Sellas, Trevena.
Read More
U.S. Securities and Exchange Commission

U.S. authorities allege Parallax exploited pandemic to bolster value of shares

July 8, 2021
By Mark McCarty
The U.S. Securities and Exchange Commission (SEC) has had Parallax Health Sciences Inc. in its crosshairs at least as far back as April 2020, when the agency suspended trading of the company’s shares. In the latest development, the SEC charged the company and two of its executives with misleading investors regarding the availability of COVID-19 screening tests and personal protective equipment, actions the agency said were undertaken to exploit the pandemic in an effort to boost the company’s share prices.
Read More

Other news to note for July 8, 2021

July 8, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Airos Medical, Cognizant, Eurofins Viracor, Fist Assist Devices, GBS, Henkel, Imprivata, Inbrain Neuroelectronics, Leica Biosystems, Magellan Rx Management, Magellan Health, Medline Industries, Merck KGaA, Mybio, Pharmed, Philips, Qualcomm, Renalsense, Si-Gene, Sonde Health, Umana Medical, Xton Technologies.
Read More
Previous 1 2 … 213 214 215 216 217 218 219 220 221 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Liver with hepatitis viruses, blood cells

    Recombinant vaccine inhibits HBV-associated HCC growth

    BioWorld Science
    Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing